Begin main content

Reports

We found 5687 result(s)

cabotegravir sodium (TBC)

Last Updated: August 19, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: cabotegravir sodium
Indications: HIV-1 infection

  • Brand Name: TBC
  • Manufacturer: ViiV Healthcare ULC
  • Project Number: SR0628-001
  • Project Status: Received
  • Submission Type: NewCombination

cabotegravir/rilpivirine (TBC)

Last Updated: August 19, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: cabotegravir-rilpivirine
Indications: HIV-1 infection

  • Brand Name: TBC
  • Manufacturer: ViiV Healthcare ULC
  • Project Number: SR0628-000
  • Project Status: Received
  • Submission Type: NewCombination

lanadelumab (Takhzyro)

Last Updated: August 19, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: lanadelumab
Indications: Hereditary angioedema, prevention

  • Brand Name: Takhzyro
  • Manufacturer: Shire Pharma Canada ULC
  • Project Number: SR0618-000
  • Project Status: Active
  • Submission Type: New

ravulizumab (TBC)

Last Updated: August 19, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: ravulizumab
Indications: Paroxysmal nocturnal hemoglobinuria.

  • Brand Name: TBC
  • Manufacturer: Alexion Pharma Canada Corp
  • Project Number: SR0623-000
  • Project Status: Suspended
  • Submission Type: New